Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality

Area of Science:

• Cardiology
• Infectious Diseases
• Immunology

Background:

• Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to millions of cases and fatalities globally.
• Cardiovascular diseases, including acute cardiac injury, hypertension, and heart failure, are common and severe complications in COVID-19 patients.
• Mechanisms involve hypoxemia, cytokine storms, ACE2 dysfunction, and drug toxicity, with macrophages playing a key role in hyperinflammation.

Purpose of the Study:

• To summarize the cardiovascular complications associated with COVID-19.
• To elucidate the underlying mechanisms contributing to cardiac disease in COVID-19 patients.
• To outline current management strategies and future research directions for cardiovascular complications in COVID-19.

Main Methods:

• Literature review and synthesis of existing research on COVID-19 and cardiovascular disease.
• Analysis of reported mechanisms of cardiac injury in COVID-19.
• Compilation of current treatment and management approaches.

Main Results:

• COVID-19 frequently leads to a range of cardiovascular issues, from arrhythmias to myocardial infarction and heart failure.
• SARS-CoV-2 infection triggers inflammatory responses and immune dysregulation, notably affecting T cells and macrophages, contributing to cardiac damage.
• Current management relies on supportive care, symptomatic treatment, and psychological support, with no specific antiviral or vaccine available.

Conclusions:

• COVID-19 poses a significant threat to cardiovascular health through various pathogenic mechanisms.
• Further research into COVID-19 pathogenesis is essential for developing targeted therapies and vaccines.
• Effective management requires a comprehensive approach addressing both the infection and its cardiovascular sequelae, especially in severe cases.